Know Cancer

or
forgot password

Endobronchial Ultrasound Guided Transbronchial Needle Aspiration for the Mediastinal Re-Staging After Induction Therapy in Non-Small Cell Lung Cancer. A Prospective Study


N/A
18 Years
N/A
Open (Enrolling)
Both
Non Small Cell Lung Cancer

Thank you

Trial Information

Endobronchial Ultrasound Guided Transbronchial Needle Aspiration for the Mediastinal Re-Staging After Induction Therapy in Non-Small Cell Lung Cancer. A Prospective Study


Inclusion Criteria:



- Histologically proven non-small cell lung cancer

- Patients who have initially histologically proven N2 disease (Stage IIIA)

- Patients who underwent induction treatment (chemotherapy or chemoradiation therapy)
and are considred for surgery

- Written informed consent

Exclusion Criteria:

- Contraindications for bronchoscopy

- Medically inoperable patients

- Patients who are found to have M1 disease, inoperable T4 disease or supraclavicular
metastasis after induction treatment

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

The diagnostic values of EBUS-TBNA in the mediastinal re-staging after induction treatment in non-small cell lung cancer.

Outcome Time Frame:

1.5 years

Safety Issue:

No

Principal Investigator

Bin Hwangbo, MD. PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Goyang, Gyeonggi-do, Korea, Republic of

Authority:

South Korea: Korea Food and Drug Administration (KFDA)

Study ID:

NCCTS-06-211

NCT ID:

NCT00859742

Start Date:

March 2009

Completion Date:

August 2010

Related Keywords:

  • Non Small Cell Lung Cancer
  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms

Name

Location